These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23433764)

  • 1. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
    Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
    J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan.
    Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H; Reis Santos K; Adragão P; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Mendes M
    Rev Port Cardiol; 2015 Jun; 34(6):395-402. PubMed ID: 26028488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J; Arbelo E; Borras R; Berne P; Tolosana JM; Gomez-Juanatey A; Berruezo A; Campuzano O; Sarquella-Brugada G; Mont L; Brugada R; Brugada J
    J Am Coll Cardiol; 2017 Oct; 70(16):1991-2002. PubMed ID: 29025556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study.
    Holst AG; Jensen HK; Eschen O; Henriksen FL; Kanters J; Bundgaard H; Svendsen JH; Haunsø S; Tfelt-Hansen J
    Europace; 2012 Jul; 14(7):1025-9. PubMed ID: 22286273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.